- Home
- VMEO vs AVDL Comparison
VMEO vs AVDL Comparison
Compare VMEO & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMEO
- AVDL
- Stock Information
- Founded
- VMEO 2004
- AVDL 2015
- Country
- VMEO United States
- AVDL Ireland
- Employees
- VMEO N/A
- AVDL N/A
- Industry
- VMEO Computer Software: Prepackaged Software
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- VMEO Technology
- AVDL Health Care
- Exchange
- VMEO Nasdaq
- AVDL Nasdaq
- Market Cap
- VMEO 900.1M
- AVDL 784.6M
- IPO Year
- VMEO N/A
- AVDL 1996
- Fundamental
- Price
- VMEO $5.27
- AVDL $7.46
- Analyst Decision
- VMEO Buy
- AVDL Strong Buy
- Analyst Count
- VMEO 3
- AVDL 7
- Target Price
- VMEO $8.67
- AVDL $18.86
- AVG Volume (30 Days)
- VMEO 1.3M
- AVDL 802.1K
- Earning Date
- VMEO 05-05-2025
- AVDL 05-07-2025
- Dividend Yield
- VMEO N/A
- AVDL N/A
- EPS Growth
- VMEO 19.88
- AVDL N/A
- EPS
- VMEO 0.16
- AVDL N/A
- Revenue
- VMEO $417,006,000.00
- AVDL $169,117,000.00
- Revenue This Year
- VMEO $4.16
- AVDL $50.53
- Revenue Next Year
- VMEO $6.76
- AVDL $32.33
- P/E Ratio
- VMEO $33.85
- AVDL N/A
- Revenue Growth
- VMEO N/A
- AVDL 504.79
- 52 Week Low
- VMEO $3.43
- AVDL $7.31
- 52 Week High
- VMEO $7.90
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- VMEO 38.18
- AVDL 34.58
- Support Level
- VMEO $5.31
- AVDL $7.98
- Resistance Level
- VMEO $5.34
- AVDL $8.31
- Average True Range (ATR)
- VMEO 0.15
- AVDL 0.33
- MACD
- VMEO 0.01
- AVDL -0.09
- Stochastic Oscillator
- VMEO 30.77
- AVDL 9.26
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. The comprehensive and cloud-based tools of the company empower its users to create, share, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.